Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibition.
Cell Death Dis
; 14(1): 5, 2023 01 05.
Article
in En
| MEDLINE
| ID: mdl-36604418
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Poly(ADP-ribose) Polymerase Inhibitors
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Cell Death Dis
Year:
2023
Type:
Article
Affiliation country:
Italy